Top 10 sales and marketing use cases for AI agents in Pharma and Healthcare

Speciality and location pages for hospital and diagnostic search

Patients search for a cardiologist, an MRI centre or a full-body check in a named neighbourhood, and often read an AI answer before they click. The digital team owns these pages; DRIS keeps each speciality, doctor and centre page accurate, structured and consistent with its Google Business Profile so search engines and answer engines can cite it.

the workflow

1. A new centre opens, a doctor joins or leaves, or the monthly Search Console report shows a speciality query losing impressions.
2. DRIS pulls the current doctor roster, timings and services from the hospital information system export and compares them with the website and each Google Business Profile.
3. It drafts page updates with structured data for the physician, department and location, and flags any mismatch in address, hours or phone number.
4. It removes outcome guarantees, success rates and before-and-after language from the draft.
5. Human approval: The marketing head and the medical director approve the page copy and doctor profiles before they go live.
6. DRIS publishes to the CMS, updates the Business Profiles and tracks whether AI answers and local results start citing the page.

Guardrail. No guaranteed outcomes, success rates or patient testimonials on doctor pages, and doctor information follows current National Medical Commission and state medical council rules on advertising by doctors and hospitals.

Condition and treatment content checked against approved claims

Brand, medical affairs and service-line teams need disease-awareness and treatment content that patients understand and reviewers can pass quickly. CREA drafts only from the approved claims library, the Pharma Strategist checks every statement against the market’s promotion rules, and reviewers see a reference beside each claim instead of hunting for one.

the workflow

1. A brand manager or service-line head files a brief, for example a disease-awareness page on thyroid testing for a diagnostics chain.
2. CREA drafts the piece using only statements from the approved claims library, each tagged with its reference.
3. The Pharma Strategist removes product names from public-facing awareness copy where prescription-drug promotion is restricted and flags any condition listed in the Drugs and Magic Remedies Act schedule.
4. CREA packages the draft, references and change log for the review system.
5. Human approval: Medical, legal and regulatory reviewers approve the final copy and its references in the review system.
6. CREA publishes the approved version and logs its expiry date for re-review.

Guardrail. Public-facing content in India never promotes a prescription drug to patients, and nothing suggests a drug treats a condition listed under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Google Ads for hospital services and OTC products within policy

Hospitals want booked consultations in service lines with open capacity; consumer health brands want OTC sales. NIA builds and runs search campaigns tied to real capacity and stock, inside Google’s Healthcare and medicines policy, and the performance lead approves every new campaign.

the workflow

1. The weekly outpatient capacity report shows open orthopaedic slots at two centres for the next fortnight.
2. NIA drafts location-targeted search campaigns for the relevant procedures, with ad copy built from approved service descriptions.
3. It screens keywords, copy and landing pages against Google’s Healthcare and medicines policy, removing prescription-drug terms and audience lists built on health conditions.
4. Human approval: The performance marketing lead approves the campaigns, budgets and ad copy before launch.
5. NIA launches, shifts budget toward centres with capacity, and pauses ads when slots fill.
6. It reports cost per booked consultation by centre and speciality each week.

Guardrail. Google Ads policy does not allow advertisers targeting India to promote prescription drugs in ads or landing pages, and OTC medicines are promoted only within the policy’s country rules.

Patient review replies that protect confidentiality

Hospitals, clinics and labs collect reviews on Google and listing platforms every day, and a careless reply can confirm that someone was a patient. Echo monitors reviews, drafts replies that never discuss care, routes complaints to patient relations and sends any possible side effect to pharmacovigilance.

the workflow

1. A one-star review lands on a clinic’s Google Business Profile describing a long wait and a reaction after an injection.
2. Echo classifies the review as a service complaint with a possible adverse event.
3. It sends the adverse event mention to the pharmacovigilance inbox at once, with the review text and timestamp.
4. It drafts a public reply that apologises for the experience and invites the reviewer to contact patient relations privately, without confirming they were a patient or referring to any treatment.
5. Human approval: The patient relations manager approves the public reply before it is posted.
6. Echo posts the reply and tracks the complaint until patient relations closes it.

Guardrail. Replies never confirm someone was a patient or discuss their care, reviews are never bought or incentivised under Google’s fake engagement policy, and possible adverse events always go to the safety team, which decides on reporting.

HCP clinical guides from approved prescribing information

Medical affairs and brand teams produce long-form material for doctors: dosing guides, scientific summaries and congress follow-ups. FOLIO drafts from the approved prescribing information and cited literature, so every claim matches the label and arrives at review with its reference.

the workflow

1. A label update is approved or a pivotal study is published in a peer-reviewed journal.
2. FOLIO drafts an HCP guide that summarises the change from the approved prescribing information and the published paper, citing the page or table behind each claim.
3. The Pharma Strategist flags any statement beyond the approved indication, any comparison without head-to-head data and any unqualified use of the word safe.
4. Human approval: Medical affairs and regulatory reviewers approve the guide, its references and its permitted audience.
5. FOLIO formats the approved version for print, rep tablets and the HCP portal, with the approval code on each.

Guardrail. The Uniform Code for Pharmaceutical Marketing Practices, 2024 requires promotional claims to be consistent with approved prescribing information and backed by evidence, so nothing off-label goes to doctors.

Corporate health and employee wellness outbound to HR buyers

Hospitals, diagnostics chains and healthtech firms sell annual health checks, on-site clinics and wellness plans to employers. NORA finds companies with a reason to buy now and researches the HR and benefits buyers, VANI drafts the first emails, and the corporate sales head approves before anything is sent.

the workflow

1. A company in the target city announces a new campus or a large hiring plan, or its wellness contract renewal date approaches.
2. NORA researches the account, identifies the HR, benefits and administration heads, and notes current wellness providers where public.
3. It builds a one-page account brief with locations, likely headcount and the packages that fit.
4. VANI drafts a first email and a follow-up that reference the trigger and offer a specific package.
5. Human approval: The corporate sales head approves the account list and the emails before anything is sent.
6. SERA sends from the rep’s mailbox, logs replies in the CRM and books meetings.

Guardrail. Business contact data is used only for the stated purpose, opt-outs are honoured, and no employee health data is ever used in prospecting, in line with the Digital Personal Data Protection Act, 2023.

Institutional sales to hospitals on expansion and tender signals

Pharma institutional teams, medtech and diagnostics suppliers sell to hospital procurement, pharmacy and department heads. NORA watches for expansion signals such as new blocks, accreditations and tenders, and SERA turns each into a researched account plan for the key account manager.

the workflow

1. A hospital chain announces a new oncology block, or a public tender for diagnostic equipment is published.
2. NORA maps the buying group: procurement, the pharmacy and therapeutics committee, biomedical engineering and the department head.
3. It drafts an account plan with the products that fit, the formulary or tender timeline and the approved materials each stakeholder may receive.
4. Human approval: The key account manager approves the account plan and the first outreach.
5. SERA sends the approved outreach, schedules meetings and logs every interaction in the CRM.

Guardrail. No gifts, travel, hospitality or payments to healthcare professionals or their families beyond what the Uniform Code for Pharmaceutical Marketing Practices, 2024 allows, and public tenders follow the buyer’s own communication rules.

Referring doctor relationship tracking for hospitals

Many admissions start with a referral from a GP, a nursing home or a diagnostic centre. RIVA watches referral patterns in the hospital system, spots drops early and prepares a visit brief, so the relationship manager arrives with something useful such as a new service or faster discharge summaries.

the workflow

1. The monthly referral export shows admissions from a long-standing referring nursing home falling sharply over two months.
2. RIVA compares the drop with service changes, discharge summary delays and waiting times in the relevant speciality.
3. It drafts a visit brief listing what changed, the hospital’s new services and the specialists the referrer works with most.
4. Human approval: The relationship manager approves the brief and the follow-up plan before the visit.
5. RIVA logs the visit outcome in the CRM and tracks that referrer’s admissions over the following months.

Guardrail. No commissions, fee-splitting or incentives for referrals, which Indian medical ethics regulations prohibit and the federal Anti-Kickback Statute prohibits in the US.

Treatment enquiry follow-up from website and WhatsApp to consult

A patient asks for a knee replacement estimate on the website or WhatsApp and waits days for a call. CORA qualifies each enquiry and routes it to the right patient coordinator with its context, and LIPI drafts the reply from approved package information so the coordinator can respond the same day.

the workflow

1. A visitor submits a cost estimate form for knee replacement and consents to be contacted.
2. CORA matches the enquiry to existing CRM records, tags speciality, city and insurance status, and routes it to the right patient coordinator.
3. LIPI drafts a reply with the approved package price range, what it includes and the documents to bring, with no clinical advice.
4. Human approval: The patient coordinator approves the reply and the proposed consultation slot.
5. SERA sends the message on the patient’s chosen channel and sets a follow-up if there is no response.

Guardrail. Contact happens only with recorded consent under the Digital Personal Data Protection Act, 2023, prices come only from approved tariffs, and every clinical question goes to a registered medical practitioner.

HCP follow-up emails and pre-call briefs from approved content

Medical representatives and key account managers get a few minutes with each doctor and follow up unevenly. LIPI prepares a pre-call brief from CRM history and drafts the follow-up from approved content only, matched to the doctor’s speciality and question, and sends it only where the doctor has consented to email.

the workflow

1. A rep schedules a Thursday visit to a cardiologist in Veeva CRM.
2. LIPI builds a pre-call brief from the doctor’s call history, past questions and the approved materials available for that speciality.
3. After the visit, the rep logs the doctor’s question in the CRM.
4. LIPI drafts a follow-up email using only the approved answer or material for that question, with its approval code attached.
5. Human approval: The rep approves the email, which can only use templates compliance has already approved.
6. SERA sends it from the rep’s address where the doctor has consented to email, and logs opens and replies in the CRM.

Guardrail. Only approved, on-label material goes to doctors, samples and brand reminders stay within the Uniform Code for Pharmaceutical Marketing Practices, 2024, and unsolicited off-label questions go to medical information.

Frequently asked questions